918
Views
8
CrossRef citations to date
0
Altmetric
Editorial

Identifying uncertainties about the effects of treatments for schizophrenia

, &
Pages 263-268 | Published online: 06 Jul 2009

References

  • Alexander J., Tharyan P., Adams C., John T., Mol C., Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. British Journal of Psychiatry 2004; 185: 63–69
  • Ballard C., Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Systematic Reviews 2006; 1, CD003476
  • Belgamwar R. B., Fenton M. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. Cochrane Database Systematic Reviews 2005; 2, CD003729
  • Chalmers I. Well informed uncertainties about the effects of treatments: How should clinicians and patients respond?. British Medical Journal 2004; 328: 475–476
  • Clark M., Chilvers C. Mental health research system in England: Yesterday, today and tomorrow. Psychiatric Bulletin 2005; 29: 441–445
  • CRASH group. Effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury (MRC CRASH Trial), randomized, placebo-controlled trial. Lancet 2004; 364: 1321–1328
  • Department of Health. Research for Patient Benefit Working Party - Final Report. Department of Health, London 2004, Gateway reference number: 3277
  • Department of Health. Best Research for Best Health – a new national health research strategy. Department of Health, London 2006, Gateway reference number: 6050
  • Fink M., Shaw R., Gross G., et al. Comparative study of chlorpromazine and insulin coma in therapy of psychosis. Journal of the American Medical Association 1958; 166: 1846–1850
  • Gibson R. C., Fenton M., Coutinho E. S., Campbell C. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database of Systematic Reviews 2004; 3, CD000525
  • Lelliott P. Beware the problems of centralisation. Commentary on “Mental health research systems in England”. Psychiatric Bulletin 2005; 29: 446–447
  • Mental Health Research Funders' Group. Strategic Analysis of UK Mental Health Research Funding. 2005, Downloadable from http://www.mrc.ac.uk/pdf-mhrfg_strategic_analysis_report_final.pdf
  • Milner K. K., Valenstein M. A comparison of guidelines for the treatment of schizophrenia. Psychiatric Services 2002; 53: 888–890
  • Rose D., Fleischmann P., Wykes T. Consumers' perspectives on ECT: A qualitative analysis. Journal of Mental Health 2004; 13: 285–294
  • Sargant W., Slater E. An introduction to physical methods of treatment in psychiatry, 1st edn. E & S Livingstone, Edinburgh 1944
  • Szmuckler G. The ground is in great shape, but can we field a kitted-out team?. Psychiatric Bulletin 2005; 29: 447–448
  • Thornicroft G., Rose D., Huxley P., Dale G., Wykes T. What are the research priorities of mental health service users? Editorial. Journal of Mental Health 2002; 11: 1–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.